1064 related articles for article (PubMed ID: 18322753)
21. Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment.
Kornmann M; Formentini A; Ette C; Henne-Bruns D; Kron M; Sander S; Baumann W; Kreuser ED; Staib L; Link KH
Eur J Surg Oncol; 2008 Dec; 34(12):1316-21. PubMed ID: 18313881
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
[TBL] [Abstract][Full Text] [Related]
23. Tumour location is a prognostic factor for survival in colonic cancer patients.
Sjo OH; Lunde OC; Nygaard K; Sandvik L; Nesbakken A
Colorectal Dis; 2008 Jan; 10(1):33-40. PubMed ID: 17672872
[TBL] [Abstract][Full Text] [Related]
24. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG
J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089
[TBL] [Abstract][Full Text] [Related]
25. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
[TBL] [Abstract][Full Text] [Related]
26. Surgical volume influences survival in patients undergoing resections for stage II colon cancers.
Morris M; Platell CF
ANZ J Surg; 2007 Oct; 77(10):902-6. PubMed ID: 17803560
[TBL] [Abstract][Full Text] [Related]
27. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Gal R; Sadikov E; Sulkes J; Klein B; Koren R
Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report.
Tominaga T; Sakabe T; Koyama Y; Hamano K; Yasutomi M; Takahashi T; Kodaira S; Kato T; Ogawa N
Cancer; 1996 Aug; 78(3):403-8. PubMed ID: 8697383
[TBL] [Abstract][Full Text] [Related]
29. Acuity and survival in colon cancer surgery.
Paulson EC; Mahmoud NN; Wirtalla C; Armstrong K
Dis Colon Rectum; 2010 Apr; 53(4):385-92. PubMed ID: 20305436
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
[TBL] [Abstract][Full Text] [Related]
31. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH
J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
[TBL] [Abstract][Full Text] [Related]
32. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification.
Radespiel-Tröger M; Hohenberger W; Reingruber B
Cancer; 2004 Mar; 100(5):958-67. PubMed ID: 14983491
[TBL] [Abstract][Full Text] [Related]
33. A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.
Schippinger W; Samonigg H; Schaberl-Moser R; Greil R; Thödtmann R; Tschmelitsch J; Jagoditsch M; Steger GG; Jakesz R; Herbst F; Hofbauer F; Rabl H; Wohlmuth P; Gnant M; Thaler J;
Br J Cancer; 2007 Oct; 97(8):1021-7. PubMed ID: 17895886
[TBL] [Abstract][Full Text] [Related]
34. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.
Le Voyer TE; Sigurdson ER; Hanlon AL; Mayer RJ; Macdonald JS; Catalano PJ; Haller DG
J Clin Oncol; 2003 Aug; 21(15):2912-9. PubMed ID: 12885809
[TBL] [Abstract][Full Text] [Related]
35. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection.
Uen YH; Lu CY; Tsai HL; Yu FJ; Huang MY; Cheng TL; Lin SR; Wang JY
Ann Surg Oncol; 2008 Aug; 15(8):2120-8. PubMed ID: 18481151
[TBL] [Abstract][Full Text] [Related]
36. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
37. [Univariate and multivariate regression analyses of recurrence and metastasis of colon cancer after radical resection].
Ren JQ; Zhou ZW; Wan DS; Lu ZH; Chen G; Wang GQ; Tang SX; Wang JJ
Ai Zheng; 2006 May; 25(5):591-5. PubMed ID: 16687080
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Taal BG; Van Tinteren H; Zoetmulder FA;
Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
